Stay updated on Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial
Sign up to get notified when there's something new on the Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial page.

Latest updates to the Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial page
- Check3 days agoChange DetectedRecruitment status is updated to no longer enrolling participants, affecting eligibility and opportunities to join. The page also adds new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and applies a minor heading reformating for Intervention/Treatment, along with a revision update to v3.6.0.SummaryDifference0.4%

- Check11 days agoChange DetectedA new revision version, v3.5.5, has been added to the page, replacing the previous v3.5.4. This indicates a minor update to the page's versioning and record-keeping.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page's revision label shows v3.5.4, replacing the previous v3.5.3. This indicates a minor internal update to the page without changes to the main content.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page’s technical revision/version footer was updated from v3.5.2 to v3.5.3, indicating a tooling or publishing update rather than a change to the study record content.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check90 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. The visible study details appear unchanged in the current view.SummaryDifference0.0%

Stay in the know with updates to Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial page.